CR10793A - Composiciones de carbamato fenilalquilo - Google Patents

Composiciones de carbamato fenilalquilo

Info

Publication number
CR10793A
CR10793A CR10793A CR10793A CR10793A CR 10793 A CR10793 A CR 10793A CR 10793 A CR10793 A CR 10793A CR 10793 A CR10793 A CR 10793A CR 10793 A CR10793 A CR 10793A
Authority
CR
Costa Rica
Prior art keywords
alkyl carbamate
phenyl alkyl
carbamate compositions
compositions
carbamate compound
Prior art date
Application number
CR10793A
Other languages
English (en)
Inventor
N Pandey Ramendra
Mascaro Tracey
Mccool James
Altan Stanley
M Railkar Aniruddha
Clark Hinton
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39111848&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR10793(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CR10793A publication Critical patent/CR10793A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invencion se relaciona con una composicion de un compuesto de carbamato fenilalquilo que resulta en estabilidad mejorada, en donde la composicion comprende un compuesto de carbamato fenilalquilo en una mezcla con una cantidad efectiva de uno o mas excipientes y, en donde por lo menos un excipiente es dihidrato de fosfato de calcio dibasico.
CR10793A 2006-10-13 2009-05-13 Composiciones de carbamato fenilalquilo CR10793A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82935506P 2006-10-13 2006-10-13

Publications (1)

Publication Number Publication Date
CR10793A true CR10793A (es) 2009-09-29

Family

ID=39111848

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10793A CR10793A (es) 2006-10-13 2009-05-13 Composiciones de carbamato fenilalquilo

Country Status (23)

Country Link
US (1) US20080090903A1 (es)
EP (1) EP2089002A1 (es)
JP (1) JP2010506846A (es)
KR (1) KR20090067210A (es)
CN (1) CN101663026A (es)
AR (1) AR063294A1 (es)
AU (1) AU2007313018A1 (es)
BR (1) BRPI0719236A2 (es)
CA (1) CA2673526A1 (es)
CL (1) CL2007002943A1 (es)
CO (1) CO6190539A2 (es)
CR (1) CR10793A (es)
EA (1) EA200970378A1 (es)
IL (1) IL198144A0 (es)
MX (1) MX2009003929A (es)
NI (1) NI200900055A (es)
NO (1) NO20091492L (es)
PE (1) PE20080887A1 (es)
SV (1) SV2009003222A (es)
TW (1) TW200831134A (es)
UY (1) UY30643A1 (es)
WO (1) WO2008048802A1 (es)
ZA (1) ZA200903284B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263652B2 (en) 2007-10-31 2012-09-11 Sk Biopharmaceuticals Co., Ltd. Stabilized pediatric suspension of carisbamate
CA2803825C (en) * 2010-07-02 2015-12-29 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
US9018253B2 (en) 2010-07-02 2015-04-28 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
EP2797880B1 (en) * 2011-12-27 2017-03-01 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating epilepsy
WO2014097137A2 (en) * 2012-12-18 2014-06-26 Mahesh Kandula Compositions and methods for the treatment of seizures and neurologic diseases
US9566261B2 (en) 2013-03-12 2017-02-14 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compound and a composition for preventing or treating a memory loss-related disease comprising the same
EP2968210B1 (en) * 2013-03-12 2024-09-11 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating pediatric epilesy
ES3059582T3 (en) * 2016-02-29 2026-03-23 Bio Pharm Solutions Co Ltd Sulfamate derivative compounds, processes for preparing them and their uses
EP3423431B1 (en) * 2016-02-29 2023-11-29 Bio-Pharm Solutions Co., Ltd. Carbamate derivative compounds and their uses
TWI905184B (zh) * 2020-05-08 2025-11-21 比利時商健生藥品公司 用醋酸阿比特龍和尼拉帕尼之組合治療前列腺癌

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US20010034365A1 (en) * 1996-01-16 2001-10-25 Choi Yong Moon Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
US20020147229A1 (en) * 2000-08-17 2002-10-10 Allerton Charlotte Moira Norfor Pharmaceuticals
JP2005510477A (ja) * 2001-10-08 2005-04-21 サン・ファーマシューティカル・インダストリーズ・リミテッド 抗痙攣薬の間隙をあけたドラッグデリバリーシステム

Also Published As

Publication number Publication date
BRPI0719236A2 (pt) 2014-07-08
US20080090903A1 (en) 2008-04-17
WO2008048802A1 (en) 2008-04-24
UY30643A1 (es) 2008-05-02
MX2009003929A (es) 2009-06-26
AU2007313018A1 (en) 2008-04-24
CA2673526A1 (en) 2008-04-24
JP2010506846A (ja) 2010-03-04
EP2089002A1 (en) 2009-08-19
CL2007002943A1 (es) 2008-04-18
NO20091492L (no) 2009-07-09
EA200970378A1 (ru) 2009-10-30
KR20090067210A (ko) 2009-06-24
CO6190539A2 (es) 2010-08-19
PE20080887A1 (es) 2008-06-28
AR063294A1 (es) 2009-01-21
CN101663026A (zh) 2010-03-03
ZA200903284B (en) 2010-07-28
NI200900055A (es) 2010-02-01
SV2009003222A (es) 2009-10-15
IL198144A0 (en) 2009-12-24
TW200831134A (en) 2008-08-01

Similar Documents

Publication Publication Date Title
CR10793A (es) Composiciones de carbamato fenilalquilo
NI200900053A (es) Composiciones de fenilalquilamino carbamato
UY30843A1 (es) Derivados de isoquinolona sustituidos con ciloalquilamina
MX343738B (es) Composiciones bioactivas de chromobacterium y metabolitos.
HN2011000699A (es) El compuesto (s)-1-({4-metil-5-[2-(2,2,2-trifluoro-1,1-dimetil-etil)-piridin-4-il]-tiazol-2-il}-amida) de 2-amida del acido pirrolidin-1,2-dicarboxilico en forma libre o de sal y composiciones y composicion farmaceutica que lo contiene.
CL2011001933A1 (es) Compuestos derivados de tetrahidropirano; y composicion pesticida que comprende a dichos compuestos.
CR9028A (es) Composiciones fungicidas sinergicas
NI200800290A (es) Moduladores bencimidazólicos de vr1
BRPI0909064A2 (pt) revestimento hidrofílico
GT200800276A (es) Composiciones farmaceuticas estabilizadas que comprenden fesoterodina
MX2011011486A (es) Composiciones orales que contienen compuestos de poliguandino y metodos de preparacion y uso de las mismas.
UY29266A1 (es) Compuestos de piridazinona
GT200800158A (es) Pirazolquinolonas como potentes inhibidores de parp
UY31560A1 (es) Azolilmetiloxiranos, su uso y agentes que los contienen
UY31925A (es) Isoquinolinas e isoquinolinonas sustituidas
BRPI0514766A (pt) composições farmacêuticas
BRPI0712889A8 (pt) composto, processo para a preparação de um composto, composto intermediário, e, composição farmacêutica.
DK1833465T3 (da) Lyofilisering af virosomer
UY30675A1 (es) Metodos para el tratamiento de la depresion
HN2011000404A (es) Derivados de enfumafungina y composicion comprendiendo los mismos
UY33092A (es) Compuestos de triazol, su uso y agentes que los contienen
GT200500311A (es) Compuestos organicos
BR112012024329B8 (pt) composições endoparasiticidas
BRPI0516602A (pt) composto, e, composição farmacêutica
NI200900050A (es) Nuevo cristal de (s)-(+)-2-(2-clorofenil)-2-hidroxi-etil carbamato

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)